To address its heterogeneity and optimize therapeutic strategies, five intrinsic molecular subtypes of breast cancer—Luminal A, Luminal B, triple-negative (TNBC), HER-2-overexpressing, and normal breast-like—have been defined based on gene expression profiling [2]. The gene discussed is ERBB2; the disease is breast carcinoma.